Egyptian Propolis Extract Attenuates Hepatotoxicity Induced by Doxorubicin via Increasing Antioxidant Defense and Decreasing Inflammatory and Apoptotic Markers: Targeting Nrf2 and Bcl-2
Almeldin, A., Younis, R., Ibrahim, R., Motawea, S., Mwafy, M., Khattab, H. (2024). Egyptian Propolis Extract Attenuates Hepatotoxicity Induced by Doxorubicin via Increasing Antioxidant Defense and Decreasing Inflammatory and Apoptotic Markers: Targeting Nrf2 and Bcl-2. EKB Journal Management System, 44(2), 69-82. doi: 10.21608/besps.2023.247742.1158
Ahmed Almeldin; Reham lotfy Younis; Rowida Raafat Ibrahim; Shaimaa Motawea; Mai Mwafy; Haidy Abdelaziz Khattab. "Egyptian Propolis Extract Attenuates Hepatotoxicity Induced by Doxorubicin via Increasing Antioxidant Defense and Decreasing Inflammatory and Apoptotic Markers: Targeting Nrf2 and Bcl-2". EKB Journal Management System, 44, 2, 2024, 69-82. doi: 10.21608/besps.2023.247742.1158
Almeldin, A., Younis, R., Ibrahim, R., Motawea, S., Mwafy, M., Khattab, H. (2024). 'Egyptian Propolis Extract Attenuates Hepatotoxicity Induced by Doxorubicin via Increasing Antioxidant Defense and Decreasing Inflammatory and Apoptotic Markers: Targeting Nrf2 and Bcl-2', EKB Journal Management System, 44(2), pp. 69-82. doi: 10.21608/besps.2023.247742.1158
Almeldin, A., Younis, R., Ibrahim, R., Motawea, S., Mwafy, M., Khattab, H. Egyptian Propolis Extract Attenuates Hepatotoxicity Induced by Doxorubicin via Increasing Antioxidant Defense and Decreasing Inflammatory and Apoptotic Markers: Targeting Nrf2 and Bcl-2. EKB Journal Management System, 2024; 44(2): 69-82. doi: 10.21608/besps.2023.247742.1158